Lombard Odier Asset Management (Switzerland) Sa Ac Immune Sa Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.5 - $5.16 $1.22 Million - $1.8 Million	-348,196 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $142,248 - $222,649	29,451 Added 9.24%	348,196 $1.72 Million
Q3 2021 Nov 12, 2021	BUY	$6.2 - $8.34 $183,433 - $246,747	29,586 Added 10.23%	318,745 $2.14 Million
Q2 2021 Aug 13, 2021	BUY	$6.04 - $8.37 $1.75 Million - $2.42 Million	289,159 New	289,159 $2.29 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.2M

Call Options Held

150K

Put Options Held

12.4K

Bvf Inc San Francisco, CA

19.5M
Shares

$69.3 Million
2.35% of portfolio
Black Rock Inc. New York, NY

2.61M
Shares

$9.26 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

1.69M
Shares

$6.01 Million
0.42% of portfolio
Wells Fargo & Company San Francisco, CA

1.11M
Shares

$3.93 Million
0.0% of portfolio
Platinum Investment Management LTD Sydney Australia 2000, C3

952K
Shares

$3.38 Million
0.17% of portfolio

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account